Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Muley

Showing results (31-40 of 224) with videos related to

Pageof 23
Sort By:
Diagnostic Pathology|December 9, 2015
Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: a large scale study of 1465 non-small cell lung cancer casesMark Kriegsmann, Thomas Muley, Alexander Harms, et al.
Cancers|December 1, 2020
Circulating Interleukin-4 Is Associated with a Systemic T Cell Response against Tumor-Associated Antigens in Treatment-Naïve Patients with Resectable Non-Small-Cell Lung CancerSeyer Safi, Yoshikane Yamauchi, Hans Hoffmann, et al.
Thoracic Cancer|January 14, 2025
Intratumor Heterogeneity Predicts Prognosis in Lepidic Predominant Lung AdenocarcinomaBenedikt Niedermaier, Michael Allgäuer, Thomas Muley, et al.
Pathology Oncology Research : POR|September 5, 2009
A histochemical approach to the diagnosis of visceral pleural infiltration by non-small cell lung cancerArne Warth, Thomas Muley, Esther Herpel, et al.
Lung Cancer (Amsterdam, Netherlands)|June 7, 2011
Urokinase receptor forms in serum from non-small cell lung cancer patients: relation to prognosisCharlotte Elberling Almasi, Ib Jarle Christensen, Gunilla Høyer-Hansen, et al.
General Thoracic and Cardiovascular Surgery|June 24, 2025
Robotic-assisted versus open resection of pulmonary sequestration: a retrospective cohort study. RATS surgery for pulmonary sequestrationHenrike Deissner, Alessio Campisi, Raffaella Griffo, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2007
Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLCThomas Muley, Timea-Helene Fetz, Hendrik Dienemann, et al.
Annals of Diagnostic Pathology|January 1, 2017
SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimensEsther Herpel, Ralf J Rieker, Hendrik Dienemann, et al.
Journal of Neurosurgery|May 31, 2024
Robotic thoracic surgery for neurogenic tumorsBenedikt Niedermaier, Raffaella Griffo, Matthias Grott, et al.
Pathology|February 26, 2019
Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancerKatharina Kriegsmann, Martin Cremer, Christiane Zgorzelski, et al.
Pageof 23

Showing results (31-40 of 224) with videos related to

Sort By:
Pageof 23
Diagnostic Pathology|December 9, 2015
Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: a large scale study of 1465 non-small cell lung cancer casesMark Kriegsmann, Thomas Muley, Alexander Harms, et al.
Cancers|December 1, 2020
Circulating Interleukin-4 Is Associated with a Systemic T Cell Response against Tumor-Associated Antigens in Treatment-Naïve Patients with Resectable Non-Small-Cell Lung CancerSeyer Safi, Yoshikane Yamauchi, Hans Hoffmann, et al.
Thoracic Cancer|January 14, 2025
Intratumor Heterogeneity Predicts Prognosis in Lepidic Predominant Lung AdenocarcinomaBenedikt Niedermaier, Michael Allgäuer, Thomas Muley, et al.
Pathology Oncology Research : POR|September 5, 2009
A histochemical approach to the diagnosis of visceral pleural infiltration by non-small cell lung cancerArne Warth, Thomas Muley, Esther Herpel, et al.
Lung Cancer (Amsterdam, Netherlands)|June 7, 2011
Urokinase receptor forms in serum from non-small cell lung cancer patients: relation to prognosisCharlotte Elberling Almasi, Ib Jarle Christensen, Gunilla Høyer-Hansen, et al.
General Thoracic and Cardiovascular Surgery|June 24, 2025
Robotic-assisted versus open resection of pulmonary sequestration: a retrospective cohort study. RATS surgery for pulmonary sequestrationHenrike Deissner, Alessio Campisi, Raffaella Griffo, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2007
Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLCThomas Muley, Timea-Helene Fetz, Hendrik Dienemann, et al.
Annals of Diagnostic Pathology|January 1, 2017
SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimensEsther Herpel, Ralf J Rieker, Hendrik Dienemann, et al.
Journal of Neurosurgery|May 31, 2024
Robotic thoracic surgery for neurogenic tumorsBenedikt Niedermaier, Raffaella Griffo, Matthias Grott, et al.
Pathology|February 26, 2019
Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancerKatharina Kriegsmann, Martin Cremer, Christiane Zgorzelski, et al.
Pageof 23